Vimarsana
Biggest News Aggregation in the World

Page 16 - Human Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Cells Today - Breaking & Trending Today

Anti-ageing function of human cell protein discovered - Vimarsana News

Anti-ageing function of human cell protein discovered

Researchers have found an anti-ageing function in a protein deep within human cells. The protein, ATSF-1, controlled the fine balance between creation of new and repair of damaged mitochondria, the part of cell responsible for producing energy, the researchers at the Queensland Brain Institute (QBI), The University of Queensland, Australia, discovered.

Source: theweek.in
2023 Treatment Guide: HIV Drug Classes - Vimarsana News

2023 Treatment Guide: HIV Drug Classes

Learn about how the different HIV drug classes control the virus in distinct ways.

Source: yahoo.com
The idea of "holobionts" represents a paradigm shift in biology - Vimarsana News

The idea of "holobionts" represents a paradigm shift in biology

These meta-organisms are made up of animals, plants, and the microbiota that live on and inside them

Source: yahoo.com
FDA Cracking Down on Unapproved HCT/Ps with Fourth Untitled Letter of 2023 | Sheppard Mullin Richter & Hampton LLP - Vimarsana News

FDA Cracking Down on Unapproved HCT/Ps with Fourth Untitled Letter of 2023 | Sheppard Mullin Richter & Hampton LLP

On May 22, 2023, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) issued an untitled letter to AT Venture Center for Global...

FDA Regulation of Human Cells and Tissues - Vimarsana News

FDA Regulation of Human Cells and Tissues

Center for Biologics Evaluation and Research is on a roll in enforcing HCT/P regulations, this enforcement trend indicates that FDA is keeping a close eye on the promotion of such products and making sure they are properly classified and undergo appropriate premarket review.